retatrutide trial news today Retatrutide, a new weight loss drug not available on the market yet, is showing promising results in trials. @DrLaPook explains it’s doing much more than what current medications can TBPN's Video on X

And I'm a big fan of that because as a clinician you need some guide, some efficient and effective way to treat the patient in front of you

Accin central sobre ncleo arcuato hipotalmico (inhibe somatostatina endgena, "quitando el freno" del eje)

In this study, we show that lipid peroxidation can serve as an upstream signaling to activate PS externalization

R.GolonkaR

Whether someone is taking a GLP-1 medication or not, maintaining strength, cardiovascular fitness, and consistent movement habits remains an important part of long-term health

Amycretin) Several leading pharmaceutical companies are advancing oral GLP-1 receptor agonists aimed at delivering powerful, needle-free alternatives to injections